• When treating dry eye disease (DED), the topical route is the most common and crucial mode of drug delivery.1 • However, acquiring the therapeutic concentration in the ocular tissue is challenging due to the eye's unique anatomical and physiological limitations.1 • Advancements in drug delivery systems using nanotechnology have been achieved in creating reliable and effective drug delivery methods.1